Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L LINDSAY

Showing results (311-320 of 346) with videos related to

Pageof 35
Sort By:
Hepatology (Baltimore, Md.)|December 25, 2007
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) TrialLeonard B Seeff, Teresa M Curto, Gyongyi Szabo, et al.
Frontiers in Psychiatry|March 29, 2024
Social perceptions and the stigmatization towards fifteen mental illnesses in France: a preliminary study on the role of vital force and burdenMichael Dambrun, Gaétan Marinho, Laurie Mondillon, et al.
Gastroenterology|September 15, 2009
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trialMitchell L Shiffman, Chihiro Morishima, Jules L Dienstag, et al.
American Journal of Obstetrics & Gynecology MFM|August 29, 2025
A Simple Data-Driven Dietary Pattern Associated with Lower Risk for Adverse Pregnancy OutcomesAndrew Batuure, George I Austin, William A Grobman, et al.
Gastroenterology|January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis CMitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Nature Communications|July 2, 2015
SCARECROW-LIKE15 interacts with HISTONE DEACETYLASE19 and is essential for repressing the seed maturation programmeMing-Jun Gao, Xiang Li, Jun Huang, et al.
Controlled Clinical Trials|October 7, 2004
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersWilliam M Lee, Jules L Dienstag, Karen L Lindsay, et al.
The Journal of Nutrition|May 4, 2026
Association between a periconception healthy plant-based diet and adverse pregnancy outcomesMcKenzie K Jancsura, William A Grobman, Jiqiang Wu, et al.
Journal of the Academy of Nutrition and Dietetics|November 14, 2024
The Relationship Between Perceived Discrimination and Reported Nutrient Intake Among Pregnant Individuals of Minoritized Racial and Ethnic GroupsTatyana Johnson, Ann K Kan, Lauren B Bonner, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis CAlan Lee Rothman, Chihiro Morishima, Herbert L Bonkovsky, et al.
Pageof 35

Showing results (311-320 of 346) with videos related to

Sort By:
Pageof 35
Hepatology (Baltimore, Md.)|December 25, 2007
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) TrialLeonard B Seeff, Teresa M Curto, Gyongyi Szabo, et al.
Frontiers in Psychiatry|March 29, 2024
Social perceptions and the stigmatization towards fifteen mental illnesses in France: a preliminary study on the role of vital force and burdenMichael Dambrun, Gaétan Marinho, Laurie Mondillon, et al.
Gastroenterology|September 15, 2009
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trialMitchell L Shiffman, Chihiro Morishima, Jules L Dienstag, et al.
American Journal of Obstetrics & Gynecology MFM|August 29, 2025
A Simple Data-Driven Dietary Pattern Associated with Lower Risk for Adverse Pregnancy OutcomesAndrew Batuure, George I Austin, William A Grobman, et al.
Gastroenterology|January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis CMitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Nature Communications|July 2, 2015
SCARECROW-LIKE15 interacts with HISTONE DEACETYLASE19 and is essential for repressing the seed maturation programmeMing-Jun Gao, Xiang Li, Jun Huang, et al.
Controlled Clinical Trials|October 7, 2004
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersWilliam M Lee, Jules L Dienstag, Karen L Lindsay, et al.
The Journal of Nutrition|May 4, 2026
Association between a periconception healthy plant-based diet and adverse pregnancy outcomesMcKenzie K Jancsura, William A Grobman, Jiqiang Wu, et al.
Journal of the Academy of Nutrition and Dietetics|November 14, 2024
The Relationship Between Perceived Discrimination and Reported Nutrient Intake Among Pregnant Individuals of Minoritized Racial and Ethnic GroupsTatyana Johnson, Ann K Kan, Lauren B Bonner, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis CAlan Lee Rothman, Chihiro Morishima, Herbert L Bonkovsky, et al.
Pageof 35